http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101409161-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101409161-B1 |
| titleOfInvention | Dihydropyrazolopyrimidinone derivative |
| abstract | The present invention relates to compounds of formula (I).n n n Formula In n n n n n n n In this formula,n n n A 1 is selected from the following formula aa1;n n n Aa1n n n n n n n n R 1 is a lower alkenyl group or a lower alkynyl group;n n n R 2 is a phenyl, pyridyl or thienyl group;n n n R 5 and R 6 are a hydrogen atom, a lower alkyl group or a hydroxy-lower alkyl group and the like.n n n The compounds of the present invention have an excellent Willkinase inhibitory effect and are therefore useful for the treatment of various cancers, particularly in the pharmaceutical field.n n n Will kinase, Cancer, Kinase inhibitor, Anticancer drug |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220081171-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102549484-B1 |
| priorityDate | 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.